| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
178,600,000 |
| Market
Cap: |
164.95(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.8901 - $1.88 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 20.7 |
| Insider 6 Months : 20.7 |
| Insider 3/6 Months : 41.5 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Precigen is a clinical-stage biopharmaceutical company improving gene and cell therapies. Co. is utilizing proprietary technology platforms to develop product candidates designed to diseases in its therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Co. is developing its clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. In addition, Co. has completed a Phase 1 study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
23,588,234 |
23,588,234 |
23,684,920 |
36,697,977 |
| Total Buy Value |
$20,049,999 |
$20,049,999 |
$20,186,326 |
$42,821,288 |
| Total People Bought |
2 |
2 |
2 |
8 |
| Total Buy Transactions |
2 |
2 |
3 |
13 |
| Total Shares Sold |
0 |
0 |
96,686 |
455,706 |
| Total Sell Value |
$0 |
$0 |
$136,327 |
$650,097 |
| Total People Sold |
0 |
0 |
1 |
6 |
| Total Sell Transactions |
0 |
0 |
1 |
21 |
| End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kirk Randal J |
Chief Executive Officer |
• • • |
2016-12-30 |
4 |
A |
$24.30 |
$999,964 |
I/I |
36,418 |
5,297,210 |
|
- |
|
| Perez Jeffrey Thomas |
SVP, IP Affairs |
• – – |
2016-12-21 |
4 |
OE |
$19.60 |
$99,980 |
D/D |
5,101 |
11,537 |
|
- |
|
| Sterling Rick L. |
Chief Financial Officer |
• – – |
2016-12-20 |
4 |
OE |
$2.65 |
$7,950 |
D/D |
3,000 |
6,369 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-12-13 |
4 |
B |
$28.90 |
$1,000,113 |
I/I |
34,606 |
213,805 |
2.64 |
- |
|
| Liffman Joel D |
SVP, Finance |
• – – |
2016-12-12 |
4 |
B |
$28.62 |
$243,265 |
D/D |
8,500 |
158,500 |
2.74 |
- |
|
| Hassan Fred |
Director |
– • – |
2016-12-01 |
4 |
B |
$29.02 |
$200,266 |
D/D |
6,900 |
6,900 |
2.39 |
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-11-30 |
4 |
A |
$29.18 |
$999,974 |
I/I |
31,348 |
5,288,980 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-10-31 |
4 |
A |
$26.10 |
$999,978 |
I/I |
37,647 |
5,282,126 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-09-30 |
4 |
A |
$27.44 |
$999,965 |
I/I |
36,291 |
5,274,464 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-08-31 |
4 |
A |
$25.24 |
$999,971 |
I/I |
35,509 |
5,267,327 |
|
- |
|
| Nimrodi Nir |
SVP-Corporate Development |
• – – |
2016-08-29 |
4 |
B |
$26.12 |
$104,484 |
I/I |
4,000 |
4,000 |
1.99 |
- |
|
| Lehr Donald P. |
Chief Legal Officer |
• – – |
2016-08-18 |
4 |
OE |
$3.18 |
$37,616 |
D/D |
11,829 |
27,155 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-08-17 |
4 |
OE |
$2.65 |
$32,911 |
I/I |
11,828 |
5,259,404 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-07-29 |
4 |
A |
$24.55 |
$999,967 |
I/I |
40,481 |
5,247,576 |
|
- |
|
| Frank Steven |
Director |
– • – |
2016-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
31,294 |
40,235 |
|
- |
|
| Frank Steven |
Director |
– • – |
2016-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
31,294 |
40,235 |
|
- |
|
| Frank Steven |
Director |
– • – |
2016-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
31,294 |
40,235 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-06-30 |
4 |
A |
$24.61 |
$999,967 |
I/I |
39,498 |
5,239,681 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-05-31 |
4 |
A |
$0.00 |
$0 |
I/I |
705,379 |
19,711 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,196,077) |
0 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-05-31 |
4 |
A |
$24.35 |
$999,989 |
I/I |
39,360 |
4,896,818 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-05-13 |
4 |
B |
$23.92 |
$1,000,574 |
I/I |
41,830 |
6,649,997 |
2.64 |
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-04-29 |
4 |
A |
$26.73 |
$999,963 |
I/I |
28,556 |
149,622 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-03-31 |
4 |
A |
$33.89 |
$999,963 |
I/I |
29,299 |
128,548 |
|
- |
|
| Kindler Jeffrey B |
Director |
– • – |
2016-03-10 |
4 |
A |
$34.99 |
$74,984 |
D/D |
2,143 |
62,815 |
|
- |
|
692 Records found
|
|
Page 23 of 28 |
|
|
0.04 (4.5%) 
